Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
approach, area, book, cumulative, Director, disposal, economic, Eleventh, exit, forfeited, forfeiture, fully, intractable, kidney, maintenance, methodology, moved, noncash, onForm, opening, Practical, practice, prohibited, reconciliation, rental, retained, satisfy, scope, suffering, tranche, underlying, uponSenior, wrote
Removed:
guide, half, Senior
Filing tables
Filing exhibits
Related press release
CARA similar filings
Filing view
External links
Exhibit 10.1
June 30, 2016
Michael Lewis, Ph.D.
Bio Diligence Partners Inc.
This letter shall serve as an eleventh amendment to the Services Agreement dated July 2, 2004. It is hereby agreed to extend the Agreement from July 1, 2016 to July 1, 2017. Compensation described in Exhibit A of the Agreement, as previously amended, will continue at the rate of $157,500.00 per annum and paid on a monthly basis. The reimbursement for 70% of the health insurance cost for consultant shall continue, paid quarterly.
All other sections of the Agreement continue as written.
| Cara Therapeutics, Inc. | ||
| By: | /s/ Derek Chalmers | |
| Name: | Derek Chalmers, Ph.D., D.Sc. | |
| Title: | President & CEO | |
| Bio Diligence Partners, Inc. | ||
| By: | /s/ Michael Lewis | |
| Name: | Michael Lewis, Ph.D. | |
| Title: | President | |